Advertisement
The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
  • E-mail E-Mail
  • Printer Friendly Printable Single-Page
  • Glossary Glossary
  • Bookmark and Share Share
U.S. Centers for Disease Control and Prevention • U.S. News

WellPoint Will Cover Merck's Gardasil

July 3, 2006

Health insurance company WellPoint Inc. said Thursday it will cover Merck & Co.'s vaccine that blocks the two types of the STD human papillomavirus (HPV) responsible for about 70 percent of cervical cancers. Earlier on Thursday, CDC's Advisory Committee on Immunization Practices recommended the Gardasil vaccine be routinely given to girls ages 11-12. Health officials estimated that more than half of sexually active women and men will be infected with one or more types of HPV in their lifetime. WellPoint said its decision to cover Gardasil was prompted by the committee's recommendation.

Back to other news for July 3, 2006

Search the Newsroom archive

Adapted from:
Associated Press
06.29.06

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
  • E-mail E-Mail
  • Printer Friendly Printable Single-Page
  • Glossary Glossary
  • Bookmark and Share Share

 

Advertisement